1-13 of 13
Sylvie Chabaud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT1-10-01: Treatment with Tucatinib in addition to Pertuzumab and Trastuzumab in patients with HER2-positive metastatic breast cancer (HER2+ MBC) after local therapy of isolated brain progression: InTTercePT, a UCBG/GINECO study

Thomas Bachelot, Christelle Jouannaud, Benjamin Verret, Sylvie Chabaud, Camille Petrau, Laetitia Stefani, Mony Ung, Isabelle Desmoulins, William Jacot, Caroline Bailleux, Sandrine Marques, Jérôme Lemonnier, Anne-Claire Hardy-Bessard
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT1-10-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT1-10-01
Published: 01 March 2023
View article titled, Abstract OT1-10-01: Treatment with Tucatinib in addition to Pertuzumab and Trastuzumab in patients with HER2-positive metastatic breast cancer (HER2+ MBC) after local therapy of isolated brain progression: InTTercePT, a UCBG/GINECO study
Journal Articles

Abstract P2-02-07: Patients’ selection of daily timing of oral intake of adjuvant hormonotherapy (HT) and everolimus (EVE) for high risk early breast cancer in the UCBG-UNIRAD phase III trial

Sylvie Giacchetti, Anne-Sophie Hamy, Thomas Bachelot, Jérôme Lemonnier, Fabrice Andre, David A. Cameron, Judith Bliss, Sylvie Chabaud, Anne-Claire Hardy-Bessard, Magali Lacroix-Triki, Jean-Luc Canon, Hervé R. Bonnefoi, Mario Campone, Paul Cottu, Florence Dalenc, Annabelle Ballesta, Francis Lévi, Enora Laas
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-02-07.
https://doi.org/10.1158/1538-7445.SABCS22-P2-02-07
Published: 01 March 2023
View article titled, Abstract P2-02-07: Patients’ selection of daily timing of oral intake of adjuvant hormonotherapy (HT) and everolimus (EVE) for high risk early breast cancer in the UCBG-UNIRAD phase III trial
Journal Articles

Abstract PD9-08: Prognostic value of EndoPredict test in patients screened for UNIRAD, a UCBG randomized, double blind, phase III international trial evaluating the addition of everolimus (EVE) to adjuvant hormone therapy (HT) in women with high risk HR+, HER2- early breast cancer (eBC)

Frederique Penault-Llorca, Florence Dalenc, Sylvie Chabaud, Paul Cottu, Djelila Allouache, David Cameron, Jean-Philippe Jacquin, Julien Grenier, Laurence Venat Bouvet, Apurna Jegannathen, Mario Campone, Francesco Del Piano, Marc Debled, Anne-Claire Hardy-Bessard, Sylvie Giacchetti, Philippe Barthelemy, Laure Kaluzinski, Audrey Mailliez, Marie-Ange Mouret-Reynier, Eric Legouffe, Anne Cayre, Mathilde Martinez, Catherine Delbaldo, Delphine Mollon-Grange, E. Jane Macaskill, Matthew Sephton, Laëtitia Stefani, Blaha Belgadi, Matthew Winter, Hubert Orfeuvre, Magali Lacroix-Triki, Herve Bonnefoi, Judith Bliss, Jean-Luc Canon, Jerome Lemonnier, Fabrice Andre, Thomas Bachelot
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD9-08.
https://doi.org/10.1158/1538-7445.SABCS21-PD9-08
Published: 15 February 2022
View article titled, Abstract PD9-08: Prognostic value of EndoPredict test in patients screened for UNIRAD, a UCBG randomized, double blind, phase III international trial evaluating the addition of everolimus (EVE) to adjuvant hormone therapy (HT) in women with high risk HR+, HER2- early breast cancer (eBC)
Journal Articles

Abstract 773: Optimizing drug regimens in oncology by clinical trial simulations: Why and how

Jocelyn Gal, Gerard Milano, Julien Viotti, Renaud Schiappa, Audrey Dugue, Agnes Paquet, Sylvie Chabaud, Jean-Marc Ferrero, Emmanuel Chamorey
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 773.
https://doi.org/10.1158/1538-7445.AM2017-773
Published: 01 July 2017
View article titled, Abstract 773: Optimizing drug regimens in oncology by clinical trial simulations: Why and how
Journal Articles

Abstract P4-11-23: Membranous ERα-36 expression is an independent predictor of poor prognosis in operable breast cancer

Loay Kassem, Soleilmane Omarjee, Sylvie Chabaud, Emilie Lavergne, Christelle Faure, Frédéric Beurrier, Olivier Tredan, Laura Corbo, Isabelle Treilleux, Muriel Le Romancer
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-23.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-23
Published: 01 May 2015
View article titled, Abstract P4-11-23: Membranous ERα-36 expression is an independent predictor of poor prognosis in operable breast cancer
Journal Articles

Abstract P4-11-24: TIF1[gamma] interacts with the TGFβ1/SMAD4 signaling leading to poorer outcome in operable breast cancer

Loay Kassem, Laurent Fattet, Jonathan Lopez, Goulvent Thibault, Emilie Lavergne, Sylvie Chabaud, Nicolas Carrabin, Nicolas Chopin, Thomas Bachelot, Germain Gillet, Isabelle Treilleux, Ruth Rimohk
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-24.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-24
Published: 01 May 2015
View article titled, Abstract P4-11-24: TIF1[gamma] interacts with the TGFβ1/SMAD4 signaling leading to poorer outcome in operable breast cancer
Journal Articles

Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns

Aurélie Swalduz, Jean-Philippe Foy, Xiaojun Jiang, Roberto Incitti, Sylvie Chabaud, David Pérol, Jean-Yves Blay, Olivier Trédan, Isabelle Treilleux, Aurélien Marabelle, Maurice Pérol, Christophe Caux, Pierre Saintigny
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-253.
https://doi.org/10.1158/1538-7445.AM2014-LB-253
Published: 01 October 2014
View article titled, Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns
Journal Articles

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1st line metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Christine Menetrier-Caux, Isabelle Ray-Coquard, Claire Cropet, Estelle Verronese, Thomas Bachelot, Olivier Tredan, Gwenaelle Garin, Pierre Heudel, Axelle N'Kodia, Ana Delgado, Christine Bardin-Dit-Courageot, Chantal Rigal, Gilles Clapisson, Sylvie Chabaud, David Perol, Paul Rebattu, Thérèse Croughs, Nicolas Pasqual, Manuarii Manuel, Michel Morre, Jean-Yves Blay, Christophe Caux
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2574.
https://doi.org/10.1158/1538-7445.AM2014-2574
Published: 01 October 2014
View article titled, Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1<sup>st</sup> line metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number
Journal Articles

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

Ray-Coquard Isabelle, Olivier Tredan, Gwenaele Garin, Christine Ménétrier-Caux, Sylvie Chabaud, Thomas Bachelot, Claire Cropet, Pierre-Etienne Heudel, Paul Rebattu, Patricia Dupont, Estelle Verronese, Anne-claire Cadore, Valérie Fouillat, Olfa Derbel, Nathalie Bonnin, Thérèse Croughs, Michel Morre, Nicolas Pasqual, Manuari Manuel, Gilles Clapisson, Christophe Caux, David Pérol, Jean-Yves Blay
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT333.
https://doi.org/10.1158/1538-7445.AM2014-CT333
Published: 01 October 2014
View article titled, Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients
Journal Articles

ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

Julien Faget, Nathalie Bendriss-Vermare, Michael Gobert, Isabelle Durand, Daniel Olive, Cathy Biota, Thomas Bachelot, Isabelle Treilleux, Sophie Goddard-Leon, Emilie Lavergne, Sylvie Chabaud, Jean Yves Blay, Christophe Caux, Christine Ménétrier-Caux
Journal: Cancer Research
Cancer Res (2012) 72 (23): 6130–6141.
https://doi.org/10.1158/0008-5472.CAN-12-2409
Published: 29 November 2012
View article titled, ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4<sup>+</sup> T Cells
Open the PDF for ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4<sup>+</sup> T Cells in another window
Includes: Supplementary data
Journal Articles

Abstract LB-165: Low TCR diversity (divpenia) is a new prognosis factor of overall survival in metastatic breast cancer

Manuarii Manuel, Olivier Tredan, Thomas Bachelot, Tioka Rabeony, Sylvie Chabaud, Jean-François Mouret, Audrey Grives, Solène Perez, Alain Puisieux, Jean-Yves Blay, Christophe Caux, Nicolas Pasqual, Christine Menetrier Caux
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-165.
https://doi.org/10.1158/1538-7445.AM2011-LB-165
Published: 15 April 2011
View article titled, Abstract LB-165: Low TCR diversity (divpenia) is a new prognosis factor of overall survival in metastatic breast cancer
Journal Articles

Abstract 1442: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype

Caroline Moyret-Lalle, Gael Grelier, Christine Lasset, Nicolas Voirin, Sylvie Chabaud, Isabelle Treilleux, Alain Puisieux
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1442.
https://doi.org/10.1158/1538-7445.AM10-1442
Published: 15 April 2010
View article titled, Abstract 1442: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
Journal Articles

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Tredan, Jaap Verweij, Pierre Biron, Inthidar Labidi, Jean-Paul Guastalla, Thomas Bachelot, David Perol, Sylvie Chabaud, Pancras C.W. Hogendoorn, Philippe Cassier, Armelle Dufresne, Jean-Yves Blay, on behalf of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5383–5391.
https://doi.org/10.1158/0008-5472.CAN-08-3845
Published: 01 July 2009
View article titled, Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Open the PDF for Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas in another window